Hoechst
and Rhone-Poulenc, merger in view
|
Bayer, uncertain beginning in 1999.
|
Eighteen-years-old in paediatrician's cure?
|
Johnson
& Johnson incorporate the Rydelle Laboratoires
|
Oncology:
from biotechnologies a further weapon
|
Ruled
bar drugs? Antitrust says no.
|